What's New at CBER

You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA)

What's New Today

The following links have been updated recently:

Posted: 4/24/2024

• FDA CBER Webinar: Considerations for the Development of CAR T Cell Products
  Webinar transcript published
• Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products - Questions and Answers; Draft Guidance for Industry
• CBER Title 21 Vacancy Announcement – Associate Director for Clinical Science, Band F, Center for Biologics Evaluation and Research (CBER), Office of Biostatistics and Pharmacovigilance (OBPV), Immediate Office of the Director (IOD)

Workshops, Meetings & Conferences

May

• Blood Products Advisory Committee Meeting
  May 9, 2024
• Vaccines and Related Biological Products Advisory Committee Meeting
  May 16, 2024
• Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development
  May 29 - 30, 2024

June

• OTP Town Hall: CMC Readiness for Gene Therapy BLAs
  June 4, 2024